Stay updated on RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial
Sign up to get notified when there's something new on the RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial page.

Latest updates to the RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe RESPONDER-HF trial record is now displayed, including its design, eligibility criteria, treatment arms, outcome measures, locations, and study dates. This provides details needed to understand and assess the heart failure study.SummaryDifference85%

- Check14 days agoChange DetectedThe footer now shows site revision v3.8.0 instead of v3.7.2. The study record still displays a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedAn NIH-wide notice appears above the navigation, linking to updates and FAQs about a terminology change from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check28 days agoChange DetectedThe footer’s site revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check35 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1, while the study record remains inaccessible with a 403 error.SummaryDifference0.2%

- Check56 days agoChange DetectedThe study page now shows a 403 Forbidden error, replacing the expected study details with an access restriction message. This indicates the record is temporarily unavailable to viewers.SummaryDifference19%

Stay in the know with updates to RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial page.